In vitro, silencing of TEAD4 in prostate cancer cells significantly inhibited cell growth (Fig. 7f for CWR22Rv1 and Supplementary Fig. 1g for PC3) and increased the cell doubling time (Fig. 7g). The gene discussed is TEAD4; the disease is Familial prostate cancer.